医学
利拉鲁肽
减肥
体重管理
内科学
肥胖
内分泌学
糖尿病
2型糖尿病
作者
Harold Bays,F. Xavier Pi‐Sunyer,Joanna Uddén,Birgitte Claudius,Christine B. Jensen,Luc Van Gaal
标识
DOI:10.1080/03007995.2016.1251892
摘要
Treatment with liraglutide 3.0 mg contributes to improved cardiometabolic parameters, AHI and health-related QoL through both weight-loss dependent and weight-loss independent mechanisms.
科研通智能强力驱动
Strongly Powered by AbleSci AI